
Loading, please wait...

Loading, please wait...

Starting dialysis represents a major life transition for many patients. Recent research highlights that peritoneal dialysis illness perception significantly dictates a patient's long-term well-being. This study examined the complex relationships between how patients view their disease and their overall quality of life (QoL). Consequently, the results identified activation, depression, and medication adherence as vital mediators in this health journey.
The researchers conducted a cross-sectional survey involving 201 initial patients. They utilized structural equation modeling to map the various pathways of clinical care. Interestingly, the findings showed that a negative perception of the illness directly correlates with higher rates of depression. Furthermore, these negative views often lead to lower medication adherence. Because patients feel less in control, they may experience a significant decline in both their physical and mental health.
Additionally, the study emphasized the critical role of patient activation. When patients feel empowered, they manage their symptoms more effectively. Therefore, healthcare providers must focus on psychological interventions during the early stages of treatment. By addressing the patient's mindset early, clinicians can improve adherence rates. Moreover, reducing depressive symptoms remains a top priority for enhancing QoL in the initial period of dialysis.
Illness perception influences how a patient emotionally reacts to their condition. Negative perceptions often lead to increased depression and poor adherence to medical advice, which ultimately lowers their quality of life.
Improving medication adherence involves boosting patient activation and addressing psychological barriers. Providing education and mental health support can help patients feel more capable of managing their treatment effectively.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.
References
Zhou Y et al. The impact of illness perception on the quality of life in initial peritoneal dialysis patients: the mediating role of activation, depression and medication adherence. Psychol Health Med. 2026 Mar 12. doi: 10.1080/13548506.2026.2643802. PMID: 41818790.
Griva K, et al. Illness perceptions and quality of life in peritoneal dialysis. Nephrology (Carlton). 2009;14(1):17-24.
Prasad N, et al. Peritoneal Dialysis in India: Challenges and the road ahead. Kidney Int Rep. 2017;2(3):305-313.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study highlights the mediating role of depression and medication adherence on quality of life in initial peritoneal dialysis patients....
7 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today